Why script-to-dispense conversion will take centre stage in 2023
pharmaphorum
JANUARY 6, 2023
In 2023, expect manufacturers to further shift their focus away from acquiring new patient prescriptions to retaining existing customers. Ensuring patient access. Retaining business begins with patient access. Preventing patient drop-off. in 1979 to 2.8%in
Let's personalize your content